home / United States / Exelixis

Exelixis Market Cap

$10.23 B

+0.22 B

NASDAQ:EXEL · April 15, 2025

Share price

$36.54

Enterprise Value

$9.11 B

Change (1-Year)

46.5%

Global Rank

#1580

Country Rank

#589

Regions

USA

Market cap

As of April 15, 2025, Exelixis (EXEL) has a market cap of $10.23 billion USD. According to our data, Exelixis is ranked No.1580 in global market value.

Sector Rank:

Biotech #72 Pharmaceuticals #67

EXEL Market Capitalization Growth

1 Years Growth:

46.5%

3 Years Growth:

46.6%

5 Years Growth:

72.3%

10 Years Growth:

977.2%

15 Years Growth:

468.8%

20 Years Growth:

362.7%

Total Growth:

128%

Exelixis Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Exelixis Market Cap CAGR Chart

Exelixis Market Cap History 2000 - 2025

Year	Market Cap	%Change
Apr 15, 2025	$10.23 B	7.54%
Dec 31, 2024	$9.51 B	38.81%
Dec 29, 2023	$6.85 B	49.56%
Dec 30, 2022	$4.58 B	-12.25%
Dec 31, 2021	$5.22 B	-8.92%
Dec 31, 2020	$5.73 B	13.90%
Dec 31, 2019	$5.03 B	-10.42%
Dec 31, 2018	$5.62 B	-35.30%
Dec 29, 2017	$8.68 B	103.89%
Dec 30, 2016	$4.26 B	164.36%
Dec 31, 2015	$1.61 B	291.67%
Dec 31, 2014	$0.41 B	-76.51%
Dec 31, 2013	$1.75 B	34.14%
Dec 31, 2012	$1.31 B	-3.59%
Dec 30, 2011	$1.35 B	-42.27%
Dec 31, 2010	$2.34 B	11.40%
Dec 31, 2009	$2.10 B	46.81%
Dec 31, 2008	$1.43 B	-41.83%
Dec 31, 2007	$2.46 B	-4.11%
Dec 29, 2006	$2.57 B	-4.46%
Dec 30, 2005	$2.69 B	-0.84%
Dec 31, 2004	$2.71 B	34.75%
Dec 31, 2003	$2.01 B	-11.87%
Dec 31, 2002	$2.28 B	-51.87%
Dec 31, 2001	$4.75 B	13.64%
Dec 29, 2000	$4.18 B	100%

Similar Companies to Exelixis

Name	Market Cap	Market cap difference	Regions
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
Merck MRK	$197.26 B	0.003 M	USA
Pfizer PFE	$127.27 B	-0.003 M	USA
AstraZeneca AZN	$210.42 B	-0.005 M	UK
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Novartis NVS	$217.12 B	0.003 M	Switzerland
Amgen AMGN	$158.77 B	0.132 B	USA
Gilead Sciences GILD	$131.74 B	-0.002 M	USA
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA
Biogen BIIB	$17.12 B	0.000 M	USA
Incyte INCY	$11.31 B	0.000 M	USA
Blueprint Medicines BPMC	$5.21 B	0.000 M	USA

About Exelixis Inc.

Name

Exelixis, Inc.

Website

https://www.exelixis.com

Headquarters

Alameda,CA

symbol

EXEL

CURRENCY

USD

country

United States

fullTimeEmployees

1147

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

EXEL Market Cap Formula

Market Cap	=	EXEL Stock Price	*	EXEL Shares Outstanding
	=	$36.54	*	0.28 B
	=	$10.23 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe